European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease ...Middle East

The expanded EU approval, applicable in all 27 countries of the bloc, is for Pfizer's Abrysvo vaccine, which was backed by the European Medicines Agency's panel of experts in March.

RSV is a common virus that can be deadly and is most dangerous for the very young and the elderly.

Both companies hit hurdles in that effort. Sales of both shots were down significantly in the U.S., the biggest market for the pharma industry, during the second autumn vaccination season since the companies launched the shots there.

The UK Health and Security Agency last week published early data from the roll out in 2024 of Pfizer's vaccine in England, showing that the shot is making a significant reduction to hospital admission rates in older people so far.

Pfizer's vaccine is currently included in four national immunisation programmes for older adults in the EU, a company spokesperson said on Tuesday.

Read More Details
Finally We wish PressBee provided you with enough information of ( European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease )

Also on site :

• Four dead and two missing after San Antonio drenched with strongest rains in more than a decade
• ‘She lit up the classroom’: First British victims of Air India plane crash named after 241 killed
• Iconic Rocker, 60, Makes Bold Statement About Having a 'Friend With Benefits'